Biblio Discovery — Demo Discovery Service

8 results for "Kassner"

Showing 1–8 · 2.34 seconds · RSS

  1. Journal Article Full text

    Influence of Mechanical Circulatory Support on Endothelin Receptor Expression in Human Left Ventricular Myocardium from Patients with Dilated Cardiomyopathy (DCM)

    Florian Gärtner; Getu Abraham; Astrid Kassner et al.

    PLOS ONE, Vol. 12 No. 1 · 2017 · English · PLOS Scopus

    Background: In terminal failing hearts ventricular assist devices (VAD) are implanted as a bridge to transplantation. Endothelin receptor (ETR) antagonists are used for treatment of secondary pulmonary hypertension in VAD patients. However, the cardiac ETR regulation in human heart failure and…

  2. Journal Article Full text

    Evolution of blood-brain-barrier permeability after acute ischemic stroke

    Zamir Merali; Kun Huang; David Mikulis et al.

    PLOS ONE, Vol. 12 No. 2 · 2017 · English · PLOS Scopus

    The dynamics of BBB permeability after AIS in humans are not well understood. In the present study we measured the evolution of BBB permeability after AIS in humans using MRI. Patients presenting to our institution with a diagnosis of AIS underwent a single dynamic contrast-enhanced MRI (DCE-MRI)…

  3. Journal Article Full text

    Neuroproteome Changes after Ischemia/Reperfusion Injury and Tissue Plasminogen Activator Administration in Rats: A Quantitative iTRAQ Proteomics Study

    Zamir Merali; Meah MingYang Gao; Tim Bowes et al.

    PLoS ONE, Vol. 9 No. 5 · 2014 · English · PLOS Scopus

    The thrombolytic, recombinant tissue plasminogen activator (rt-PA) is the only approved therapy for acute ischemic stroke (AIS). When administered after AIS, rt-PA has many adverse pleiotropic actions, which are currently poorly understood. The identification of proteins showing differential…

  4. Journal Article Full text

    Higher Lipoprotein (a) Levels Are Associated with Better Pulmonary Function in Community-Dwelling Older People – Data from the Berlin Aging Study II

    Nikolaus Buchmann; Ursula Kassner; Kristina Norman et al.

    PLOS ONE, Vol. 10 No. 9 · 2015 · English · PLOS Scopus

    Reduced pulmonary function and elevated serum cholesterol levels are recognized risk factors for cardiovascular disease. Currently, there is some controversy concerning relationships between cholesterol, LDL-cholesterol, HDL-cholesterol, serum triglycerides and lung function. However, most previous…

  5. Journal Article Full text

    Measurement of Cancer Cell Growth Heterogeneity through Lentiviral Barcoding Identifies Clonal Dominance as a Characteristic of In Vivo Tumor Engraftment

    Olivier Nolan-Stevaux; Donato Tedesco; Seamus Ragan et al.

    PLoS ONE, Vol. 8 No. 6 · 2013 · English · PLOS Scopus

    Advances in the fields of cancer initiating cells and high-throughput in vivo shRNA screens have highlighted a need to observe the growth of tumor cells in cancer models at the clonal level. While in vivo cancer cell growth heterogeneity in xenografts has been described, it has yet to be measured…

  6. Journal Article Full text

    High proportion of genetic cases in patients with advanced cardiomyopathy including a novel homozygous Plakophilin 2 -gene mutation

    Baerbel Klauke; Anna Gaertner-Rommel; Uwe Schulz et al.

    PLOS ONE, Vol. 12 No. 12 · 2017 · English · PLOS Scopus

    Cardiomyopathies might lead to end-stage heart disease with the requirement of drastic treatments like bridging up to transplant or heart transplantation. A not precisely known proportion of these diseases are genetically determined. We genotyped 43 index-patients (30 DCM, 10 ARVC, 3 RCM) with…

  7. Journal Article Full text

    EBV + tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22

    Aparna Jorapur; Lisa A. Marshall; Scott Jacobson et al.

    PLOS Pathogens, Vol. 18 No. 1 · 2022 · English · PLOS Scopus

    The Epstein-Barr Virus (EBV) is involved in the etiology of multiple hematologic and epithelial human cancers. EBV+ tumors employ multiple immune escape mechanisms, including the recruitment of immunosuppressive regulatory T cells (Treg). Here, we show some EBV+ tumor cells express high levels of…

  8. Journal Article Full text

    Sphingosine Kinase Activity Is Not Required for Tumor Cell Viability

    Karen Rex; Shawn Jeffries; Matthew L. Brown et al.

    PLoS ONE, Vol. 8 No. 7 · 2013 · English · PLOS Scopus

    Sphingosine kinases (SPHKs) are enzymes that phosphorylate the lipid sphingosine, leading to the formation of sphingosine-1-phosphate (S1P). In addition to the well established role of extracellular S1P as a mitogen and potent chemoattractant, SPHK activity has been postulated to be an important…